Lei Wu1, Yi Lyu2, Ramkumar Srinivasagan3, Jinlong Wu4, Babajide Ojo1, Minghua Tang5, Guadalupe Davilla El-Rassi6, Katherine Metzinger1, Brenda J Smith1, Edralin A Lucas1, Stephen L Clarke1, Winyoo Chowanadisai1, Xinchun Shen2, Hui He7, Tyrrell Conway7, Johannes von Lintig3, Dingbo Lin1. 1. Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK, USA. 2. College of Food Science and Engineering/Collaborative Innovation Center for Modern Grain Circulation and Safety/Key Laboratory of Grains and Oils Quality Control and Processing, Nanjing University of Finance and Economics, Nanjing, China. 3. Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH, USA. 4. Key Laboratory of Horticultural Plant Biology (Ministry of Education), Huazhong Agricultural University, Wuhan, China. 5. Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. 6. Food and Agricultural Products Center, Oklahoma State University, Stillwater, OK, USA. 7. Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, USA.
Abstract
BACKGROUND: Astaxanthin is a red lipophilic carotenoid that is often undetectable in human plasma due to the limited supply in typical Western diets. Despite its presence at lower than detectable concentrations, previous clinical feeding studies have reported that astaxanthin exhibits potent antioxidant properties. OBJECTIVE: We examined astaxanthin accumulation and its effects on gut microbiota, inflammation, and whole-body metabolic homeostasis in wild-type C57BL/6 J (WT) and β-carotene oxygenase 2 (BCO2) knockout (KO) mice. METHODS: Six-wk-old male and female BCO2 KO and WT mice were provided with either nonpurified AIN93M (e.g., control diet) or the control diet supplemented with 0.04% astaxanthin (wt/wt) ad libitum for 8 wk. Whole-body energy expenditure was measured by indirect calorimetry. Feces were collected from individual mice for short-chain fatty acid assessment. Hepatic astaxanthin concentrations and liver metabolic markers, cecal gut microbiota profiling, inflammation markers in colonic lamina propria, and plasma samples were assessed. Data were analyzed by 3-way ANOVA followed by Tukey's post hoc analysis. RESULTS: BCO2 KO but not WT mice fed astaxanthin had ∼10-fold more of this compound in liver than controls (P < 0.05). In terms of the microbiota composition, deletion of BCO2 was associated with a significantly increased abundance of Mucispirillum schaedleri in mice regardless of gender. In addition to more liver astaxanthin in male KO compared with WT mice fed astaxanthin, the abundance of gut Akkermansia muciniphila was 385% greater, plasma glucagon-like peptide 1 was 27% greater, plasma glucagon and IL-1β were 53% and 30% lower, respectively, and colon NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome activation was 23% lower (all P < 0.05) in male KO mice than the WT mice. CONCLUSIONS: Astaxanthin affects the gut microbiota composition in both genders, but the association with reductions in local and systemic inflammation, oxidative stress, and improvement of metabolic homeostasis only occurs in male mice.
BACKGROUND:Astaxanthin is a red lipophilic carotenoid that is often undetectable in human plasma due to the limited supply in typical Western diets. Despite its presence at lower than detectable concentrations, previous clinical feeding studies have reported that astaxanthin exhibits potent antioxidant properties. OBJECTIVE: We examined astaxanthin accumulation and its effects on gut microbiota, inflammation, and whole-body metabolic homeostasis in wild-type C57BL/6 J (WT) and β-carotene oxygenase 2 (BCO2) knockout (KO) mice. METHODS: Six-wk-old male and female BCO2 KO and WT mice were provided with either nonpurified AIN93M (e.g., control diet) or the control diet supplemented with 0.04% astaxanthin (wt/wt) ad libitum for 8 wk. Whole-body energy expenditure was measured by indirect calorimetry. Feces were collected from individual mice for short-chain fatty acid assessment. Hepatic astaxanthin concentrations and liver metabolic markers, cecal gut microbiota profiling, inflammation markers in colonic lamina propria, and plasma samples were assessed. Data were analyzed by 3-way ANOVA followed by Tukey's post hoc analysis. RESULTS:BCO2 KO but not WT mice fed astaxanthin had ∼10-fold more of this compound in liver than controls (P < 0.05). In terms of the microbiota composition, deletion of BCO2 was associated with a significantly increased abundance of Mucispirillum schaedleri in mice regardless of gender. In addition to more liver astaxanthin in male KO compared with WT mice fed astaxanthin, the abundance of gut Akkermansia muciniphila was 385% greater, plasma glucagon-like peptide 1 was 27% greater, plasma glucagon and IL-1β were 53% and 30% lower, respectively, and colon NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome activation was 23% lower (all P < 0.05) in male KO mice than the WT mice. CONCLUSIONS:Astaxanthin affects the gut microbiota composition in both genders, but the association with reductions in local and systemic inflammation, oxidative stress, and improvement of metabolic homeostasis only occurs in male mice.
Authors: Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Zhengqing Shen; Hassan Sharifzadeh; Brian M Besch; Kelly Nelson; Madeleine M Horvath; Jeanne M Frederick; Wolfgang Baehr; Paul S Bernstein Journal: Proc Natl Acad Sci U S A Date: 2014-06-30 Impact factor: 11.205
Authors: V Rainone; L Schneider; I Saulle; C Ricci; M Biasin; N M Al-Daghri; E Giani; G V Zuccotti; M Clerici; D Trabattoni Journal: Int J Obes (Lond) Date: 2016-02-15 Impact factor: 5.095
Authors: E D Brown; M S Micozzi; N E Craft; J G Bieri; G Beecher; B K Edwards; A Rose; P R Taylor; J C Smith Journal: Am J Clin Nutr Date: 1989-06 Impact factor: 7.045
Authors: Grzegorz Palczewski; M Airanthi K Widjaja-Adhi; Jaume Amengual; Marcin Golczak; Johannes von Lintig Journal: J Lipid Res Date: 2016-07-07 Impact factor: 5.922
Authors: María Marhuenda-Muñoz; Sara Hurtado-Barroso; Anna Tresserra-Rimbau; Rosa Maria Lamuela-Raventós Journal: Eur J Clin Nutr Date: 2019-07 Impact factor: 4.016
Authors: Kunal Pratap; Marwan E Majzoub; Aya C Taki; Socorro Miranda Hernandez; Marie Magnusson; Christopher R K Glasson; Rocky de Nys; Torsten Thomas; Andreas L Lopata; Sandip D Kamath Journal: Foods Date: 2022-02-16